# Low Level Laser Therapy Versus Benzydamin in Prevention and Treatment of Oral Mucositis

> **NCT05034068** · EARLY_PHASE1 · COMPLETED · sponsor: **Al-Azhar University** · enrollment: 90 (actual)

## Conditions studied

- Stomatitis (Oral Mucositis)

## Interventions

- **DRUG:** 0.15% bezaydamine hydrochloride.
- **DEVICE:** low power laser with a wavelength of 870 nm

## Key facts

- **NCT ID:** NCT05034068
- **Lead sponsor:** Al-Azhar University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-05
- **Primary completion:** 2022-01-30
- **Final completion:** 2022-02-01
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2022-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05034068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05034068, "Low Level Laser Therapy Versus Benzydamin in Prevention and Treatment of Oral Mucositis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05034068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*